These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 28750770)
1. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Ali HEA; Abdel Hameed R; Effat H; Ahmed EK; Atef AA; Sharawi SK; Ali M; Abd Elmageed ZY; Abdel Wahab AH Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e51-e62. PubMed ID: 28750770 [TBL] [Abstract][Full Text] [Related]
2. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
3. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
4. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041 [TBL] [Abstract][Full Text] [Related]
6. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
7. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [TBL] [Abstract][Full Text] [Related]
8. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
10. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma. Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228 [TBL] [Abstract][Full Text] [Related]
11. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Li L; Guo Z; Wang J; Mao Y; Gao Q Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399 [TBL] [Abstract][Full Text] [Related]
12. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
13. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma. El-Hamouly MS; Azzam AA; Ghanem SE; El-Bassal FI; Shebl N; Shehata AMF Mol Biol Rep; 2019 Dec; 46(6):5759-5765. PubMed ID: 31471732 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage. Sun Q; Li J; Jin B; Wang T; Gu J Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500 [TBL] [Abstract][Full Text] [Related]
17. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related]
18. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Zhou J; Yu L; Gao X; Hu J; Wang J; Dai Z; Wang JF; Zhang Z; Lu S; Huang X; Wang Z; Qiu S; Wang X; Yang G; Sun H; Tang Z; Wu Y; Zhu H; Fan J J Clin Oncol; 2011 Dec; 29(36):4781-8. PubMed ID: 22105822 [TBL] [Abstract][Full Text] [Related]
19. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818 [TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]